# MR Correlated Spectroscopic Imaging for Diagnosing Breast Cancer

> **NCT06090630** · EARLY_PHASE1 · COMPLETED · sponsor: **Jonsson Comprehensive Cancer Center** · enrollment: 83 (actual)

## Conditions studied

- Benign Breast Neoplasm
- Breast Carcinoma
- Malignant Breast Neoplasm

## Interventions

- **PROCEDURE:** Diffusion Weighted Imaging
- **PROCEDURE:** Magnetic Resonance Spectroscopic Imaging

## Key facts

- **NCT ID:** NCT06090630
- **Lead sponsor:** Jonsson Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-31
- **Primary completion:** 2023-02-03
- **Final completion:** 2023-02-03
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2024-04-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06090630

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06090630, "MR Correlated Spectroscopic Imaging for Diagnosing Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06090630. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*